NUTRACEUTICAL INTERNATIONAL CORP 4
4 · NUTRACEUTICAL INTERNATIONAL CORP · Filed Sep 23, 2013
Insider Transaction Report
Form 4
GAY FRANK W II
DirectorChairman & CEO
Transactions
- Sale
Common Stock
2013-09-23$23.10/sh−2,795$64,559→ 733,399 total - Exercise/Conversion
Employee Stock Option (right to buy)
2013-09-23−2,795→ 0 totalExercise: $12.32Exp: 2013-12-17→ Common Stock (2,795 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2013-09-20−7,205→ 2,795 totalExercise: $12.32Exp: 2013-12-17→ Common Stock (7,205 underlying) - Exercise/Conversion
Common Stock
2013-09-20$23.37/sh+7,205$168,363→ 740,604 total - Exercise/Conversion
Common Stock
2013-09-23$12.32/sh+2,795$34,434→ 736,194 total - Sale
Common Stock
2013-09-20$23.37/sh−7,205$168,363→ 733,399 total
Footnotes (5)
- [F1]Exercise of options expiring on December 17, 2013.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 19, 2013.
- [F3]The price shown in Column 4 is a weighted average sale price. The price range for the sales is $23.00 to $23.68. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]The price shown in Column 4 is a weighted average sale price. The price range for the sales is $22.79 to $23.25. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F5]The option vested in six equal installments every six months beginning on June 17, 2004.